Skip to main content

Advertisement

SpringerLink
Log in

Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Studies of late stages of Parkinson’s disease (LS-PD) are limited. To provide an adequate health plan for patients in these most advanced stages, accurate information on their clinical condition is necessary. We characterize clinical features and medication use of LS-PD. A cross-sectional study of LS-PD stage 4 or 5 of Hoehn and Yahr during on states is presented in this paper. Demographics, clinical features and medication data were obtained using a structured questionnaire and physical examination. Patients were asked to grade the perceived impact of symptoms on their health status. Fifty patients (mean age 74.1 years and mean disease duration 17.9 years) were studied. Severe akinetic symmetric parkinsonism was present in most, with negligible rigidity and tremor, and most patients were wheelchair-bound. Severe postural instability and freezing of gait, causing frequent falls and fractures, and prominent dysarthria and dysphagia dominated the motor syndrome. Levodopa remained effective in most patients in relieving motor symptoms including tremor. Motor fluctuations and dyskinesias were present in 78 and 62% of patients, respectively, but were not perceived as disabling. All had neuropsychiatric and dysautonomic symptoms. Visual hallucinations were present in 44%, depression in 62% and dementia in 50%. Lack of tremor (p < 0.01) and absence of depression (p < 0.01) were independently associated with dementia (R 2 = 45%). Symptoms causing greatest impact on perceived health status were falls, gait unsteadiness, urinary dysfunction and sweats. Motor and non-motor non-levodopa responsive problems were frequent and the main cause of disability. Fluctuations and dyskinesias were frequent though not disabling. Dementia is not unavoidable in these very late stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Martin WE, Loewenson RB, Resch JA et al (1973) Parkinson’s disease. Clinical analysis of 100 patients. Neurology 23:783–790

    CAS  PubMed  Google Scholar 

  2. Papapetropoulos S, Gonzalez J, Lieberman A et al (2005) Dementia in Parkinson’s disease: a post-mortem study in a population of brain donors. Int J Geriatr Psychiatry 20:418–422

    Article  CAS  PubMed  Google Scholar 

  3. Aarsland D, Larsen JP, Cummins JL et al (1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56:595–601

    Article  CAS  PubMed  Google Scholar 

  4. Hely MA, Morris JG, Reid WG et al (2005) Sydney multicenter study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Mov Disord 20:190–199

    Article  PubMed  Google Scholar 

  5. Hely MA, Reid WG, Adena MA et al (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844

    Article  PubMed  Google Scholar 

  6. Clarke CE (1993) Mortality from Parkinson’s disease in England and Wales 1921–89. J Neurol Neurosurg Psychiatry 56:690–693

    Article  CAS  PubMed  Google Scholar 

  7. Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  CAS  PubMed  Google Scholar 

  8. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442

    CAS  PubMed  Google Scholar 

  9. Fahn S, Elton RL (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Healthcare Information, Florham Park, pp 153–163

    Google Scholar 

  10. Uitti RJ, Baba Y, Whaley NR et al (2005) Parkinson disease: handedness predicts asymmetry. Neurology 64:1925–1930

    Article  CAS  PubMed  Google Scholar 

  11. Witjas T, Kaphan E, Azulay JP et al (2002) Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology 59:408–413

    PubMed  Google Scholar 

  12. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington

    Google Scholar 

  13. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  CAS  PubMed  Google Scholar 

  14. Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    CAS  PubMed  Google Scholar 

  15. Den Oudsten BL, Van Heck GL, De Vries J (2007) Quality of life and related concepts in Parkinson’s disease: a systematic review. Mov Disord 22:1528–1537

    Article  Google Scholar 

  16. Papapetropoulos S, Mash DC (2007) Motor fluctuations and dyskinesias in advanced/end stage Parkinson’s disease: a study from a population of brain donors. J Neural Transm 114:341–345

    Article  CAS  PubMed  Google Scholar 

  17. Hely MA, Morris JG, Traficante R et al (1999) The Sydney multicenter study of Parkinson’s disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 67:300–307

    Article  CAS  PubMed  Google Scholar 

  18. Hughes AJ, Daniel SE, Blankson S et al (1993) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50:140–148

    CAS  PubMed  Google Scholar 

  19. Pickering RM, Grimbergen YA, Rigney U et al (2007) A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord 22:1892–1900

    Article  PubMed  Google Scholar 

  20. Muller J, Wenning GK, Verny M et al (2001) Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 58:259–264

    Article  CAS  PubMed  Google Scholar 

  21. Kempster PA, Williams DR, Selikhova M et al (2007) Patterns of levodopa response in Parkinson’s disease: a clinico-pathological study. Brain 130:2123–2128

    Article  CAS  PubMed  Google Scholar 

  22. Aarsland D, Larsen JP, Lim NG et al (1999) Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:492–496

    Article  CAS  PubMed  Google Scholar 

  23. Aarsland D, Bronnick K, Ehrt U et al (2007) Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 78:36–42

    Article  CAS  PubMed  Google Scholar 

  24. Schrag A, Barone P, Brown RG et al (2007) Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 22:1077–1092

    Article  PubMed  Google Scholar 

  25. Fenelon G, Mahieux F, Huon R et al (2000) Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 123:733–745

    Article  PubMed  Google Scholar 

  26. Papapetropoulos S, Argyriou AA, Ellul J (2005) Factors associated with drug-induced visual hallucinations in Parkinson’s disease. J Neurol 252:1223–1228

    Article  PubMed  Google Scholar 

  27. Aarsland D, Andersen K, Larsen JP et al (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387–392

    Article  PubMed  Google Scholar 

  28. Marras C, Rochon P, Lang AE (2002) Predicting motor decline and disability in Parkinson disease: a systematic review. Arch Neurol 59:1724–1728

    Article  PubMed  Google Scholar 

  29. Zetusky WJ, Jankovic J, Pirozzolo FJ (1985) The heterogeneity of Parkinson’s disease: clinical and prognostic implications. Neurology 35:522–526

    CAS  PubMed  Google Scholar 

  30. Giladi N, Treves TA, Paleacu D et al (2000) Risk factors for dementia, depression and psychosis in long-standing Parkinson’s disease. J Neural Transm 107:59–71

    Article  CAS  PubMed  Google Scholar 

  31. Tandberg E, Larsen JP, Aarsland D et al (1996) The occurrence of depression in Parkinson’s disease a community-based study. Arch Neurol 53:175–179

    CAS  PubMed  Google Scholar 

  32. Aarsland D, Tandberg E, Larsen JP et al (1996) Frequency of dementia in Parkinson disease. Arch Neurol 53:538–542

    CAS  PubMed  Google Scholar 

  33. Negre-Pages L, Regragui W, Bouhassira D et al (2008) Chronic pain in Parkinson’s disease: the cross-sectional French DoPaMiP survey. Mov Disord 23:1361–1369

    Article  PubMed  Google Scholar 

  34. Defazio G, Berardelli A, Fabbrini G et al (2008) Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65:1191–1194

    Article  PubMed  Google Scholar 

  35. Krack P, Batir A, Van Blecom N et al (2003) Five-year follow-up of bilateral stimulation of the sub-thalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349(20):1925–1934

    Article  CAS  PubMed  Google Scholar 

  36. Deuschl G, Shade-Brittinger C, Krack P et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355(9):896–908

    Article  CAS  PubMed  Google Scholar 

  37. Braak H, Del Tredici K, Rub U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

    Article  PubMed  Google Scholar 

  38. Apaydin H, Ahlskog JE, Parisi JE et al (2002) Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 59:102–112

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The medical ethics committees of the hospitals involved approved the study.

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. Neurological Clinical Research Unit, Instituto de Medicina Molecular, Hospital Santa Maria, Lisbon, Portugal

    Miguel Coelho, Joaquim J. Ferreira, Mário Rosa & Cristina Sampaio

  2. Movement Disorders Unit, Neurology Service, Hospital Clinic, Centro de Investigacion en Red de Enfermedades Neurodegenerativas (CIBERNED), University of Barcelona, Barcelona, Spain

    Maria J. Marti, Eduardo Tolosa & Francesc Valldeoriola

  3. Serviço Neurologia, Piso 6, Hospital de Santa Maria, Lisbon, 1649-035, Portugal

    Miguel Coelho

Authors
  1. Miguel Coelho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria J. Marti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eduardo Tolosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joaquim J. Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesc Valldeoriola
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mário Rosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cristina Sampaio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miguel Coelho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coelho, M., Marti, M.J., Tolosa, E. et al. Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort. J Neurol 257, 1524–1532 (2010). https://doi.org/10.1007/s00415-010-5566-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5566-8

Keywords

Search

Navigation